{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:59:27Z","timestamp":1780732767900,"version":"3.54.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T00:00:00Z","timestamp":1757980800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["li.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Laboratory Investigation"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.labinv.2025.104242","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:16:31Z","timestamp":1758086191000},"page":"104242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Detailed Characterization and Comparison of Mouse Models for Cholangiocarcinoma"],"prefix":"10.1016","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-3854-5288","authenticated-orcid":false,"given":"Margaret","family":"Tulessin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-7838-1982","authenticated-orcid":false,"given":"Ludwig","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5333-5942","authenticated-orcid":false,"given":"Stephanie","family":"Roessler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"Beckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2038-1408","authenticated-orcid":false,"given":"Darko","family":"Castven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego Francesco","family":"Calvisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9588-0164","authenticated-orcid":false,"given":"Xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0406-1401","authenticated-orcid":false,"given":"Sebastian","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5977-5375","authenticated-orcid":false,"given":"Nicole","family":"Pfarr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8314-2682","authenticated-orcid":false,"given":"Jens","family":"Marquardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa Hildegard","family":"Wirtz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Luise","family":"Berres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7269-5433","authenticated-orcid":false,"given":"Katja","family":"Steiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9049-9145","authenticated-orcid":false,"given":"Tanja","family":"Groll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3400-7254","authenticated-orcid":false,"given":"Carolin","family":"Mogler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.labinv.2025.104242_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","article-title":"Cholangiocarcinoma","volume":"7","author":"Brindley","year":"2021","journal-title":"Nat Rev Dis Primers"},{"issue":"2","key":"10.1016\/j.labinv.2025.104242_bib2","article-title":"Cell of origin in biliary tract cancers and clinical implications","volume":"3","author":"Moeini","year":"2021","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.labinv.2025.104242_bib3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jhep.2023.03.010","article-title":"EASL-ILCA Clinical Practice Guidelines on the management of intrahepatic cholangiocarcinoma","volume":"79","year":"2023","journal-title":"J Hepatol"},{"issue":"21","key":"10.1016\/j.labinv.2025.104242_bib4","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.3390\/cancers14215358","article-title":"Pathologies of precursor lesions of biliary tract carcinoma","volume":"14","author":"Nakanuma","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.labinv.2025.104242_bib5","first-page":"254","volume":"Vol. 1","year":"2019"},{"issue":"6","key":"10.1016\/j.labinv.2025.104242_bib6","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1053\/j.gastro.2013.10.013","article-title":"Pathogenesis, diagnosis, and management of cholangiocarcinoma","volume":"145","author":"Ilyas","year":"2013","journal-title":"Gastroenterology"},{"issue":"13","key":"10.1016\/j.labinv.2025.104242_bib7","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.3390\/cancers14133093","article-title":"Changing epidemiological trends of hepatobiliary carcinomas in Austria 2010-2018","volume":"14","author":"Hucke","year":"2022","journal-title":"Cancers"},{"issue":"3","key":"10.1016\/j.labinv.2025.104242_bib8","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"10.1016\/j.labinv.2025.104242_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2022.100737","article-title":"Clinical treatment of cholangiocarcinoma: an updated comprehensive review","volume":"27","author":"Elvevi","year":"2022","journal-title":"Ann Hepatol"},{"issue":"7","key":"10.1016\/j.labinv.2025.104242_bib10","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41575-022-00739-y","article-title":"Criteria for preclinical models of cholangiocarcinoma: scientific and medical relevance","volume":"20","author":"Calvisi","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.labinv.2025.104242_bib11","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/gutjnl-2023-330029","article-title":"British Society of Gastroenterology guidelines for the diagnosis and management of cholangiocarcinoma","volume":"73","author":"Rushbrook","year":"2023","journal-title":"Gut"},{"issue":"9","key":"10.1016\/j.labinv.2025.104242_bib12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/s41575-020-0310-z","article-title":"Cholangiocarcinoma 2020: the next horizon in mechanisms and management","volume":"17","author":"Banales","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"suppl 6","key":"10.1016\/j.labinv.2025.104242_bib13","doi-asserted-by":"crossref","first-page":"VI1","DOI":"10.1136\/gut.51.suppl_6.vi1","article-title":"Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document","volume":"51","author":"Khan","year":"2002","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.labinv.2025.104242_bib14","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/nrclinonc.2017.157","article-title":"Cholangiocarcinoma\u2014evolving concepts and therapeutic strategies","volume":"15","author":"Ilyas","year":"2018","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"10.1016\/j.labinv.2025.104242_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41392-024-01814-3","article-title":"Cholangiocarcinoma combined with biliary obstruction: an exosomal circRNA signature for diagnosis and early recurrence monitoring","volume":"9","author":"Wen","year":"2024","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"10.1016\/j.labinv.2025.104242_bib16","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.bbadis.2018.03.026","article-title":"Animal models of cholangiocarcinoma","volume":"1865","author":"Loeuillard","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"10","key":"10.1016\/j.labinv.2025.104242_bib17","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1136\/gutjnl-2023-331237","article-title":"PARP-1 selectively impairs KRAS-driven phenotypic and molecular features in intrahepatic cholangiocarcinoma","volume":"73","author":"Keggenhoff","year":"2024","journal-title":"Gut"},{"issue":"15","key":"10.1016\/j.labinv.2025.104242_bib18","doi-asserted-by":"crossref","first-page":"3128","DOI":"10.1038\/s41388-020-1198-3","article-title":"NOTCH target gene HES5 mediates oncogenic and tumor suppressive functions in hepatocarcinogenesis","volume":"39","author":"Luiken","year":"2020","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.labinv.2025.104242_bib19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jhep.2019.05.027","article-title":"Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis","volume":"71","author":"Wang","year":"2019","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.labinv.2025.104242_bib20","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1016\/j.celrep.2017.02.033","article-title":"Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles","volume":"18","author":"Farshidfar","year":"2017","journal-title":"Cell Rep"},{"issue":"24","key":"10.1016\/j.labinv.2025.104242_bib21","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1038\/s41388-018-0188-1","article-title":"Notch2 controls hepatocyte-derived cholangiocarcinoma formation in mice","volume":"37","author":"Wang","year":"2018","journal-title":"Oncogene"},{"issue":"6","key":"10.1016\/j.labinv.2025.104242_bib22","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.jhep.2017.07.006","article-title":"Pan-mTOR inhibitor MLN0128 is effective against intrahepatic cholangiocarcinoma in mice","volume":"67","author":"Zhang","year":"2017","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.labinv.2025.104242_bib23","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.ccr.2013.04.019","article-title":"A critical role for notch signaling in the formation of cholangiocellular carcinomas","volume":"23","author":"Zender","year":"2013","journal-title":"Cancer Cell"},{"issue":"6","key":"10.1016\/j.labinv.2025.104242_bib24","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.dld.2012.10.008","article-title":"Liver carcinogenesis: rodent models of hepatocarcinoma and cholangiocarcinoma","volume":"45","author":"De Minicis","year":"2013","journal-title":"Dig Liver Dis"},{"issue":"8","key":"10.1016\/j.labinv.2025.104242_bib25","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.1172\/JCI63212","article-title":"Cholangiocarcinomas can originate from hepatocytes in mice","volume":"122","author":"Fan","year":"2012","journal-title":"J Clin Invest"},{"issue":"7 Suppl","key":"10.1016\/j.labinv.2025.104242_bib26","doi-asserted-by":"crossref","first-page":"5S","DOI":"10.1177\/0192623310386499","article-title":"Proliferative and nonproliferative lesions of the rat and mouse hepatobiliary system","volume":"38","author":"Thoolen","year":"2010","journal-title":"Toxicol Pathol"},{"issue":"1","key":"10.1016\/j.labinv.2025.104242_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13550-021-00826-2","article-title":"Correlation of in vivo imaging to morphomolecular pathology in translational research: challenge accepted","volume":"11","author":"Ballke","year":"2021","journal-title":"EJNMMI Res"},{"issue":"2","key":"10.1016\/j.labinv.2025.104242_bib28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1007\/s00292-018-0458-2","article-title":"[Histopathological research laboratories in translational research : conception and integration into the infrastructure of pathological institutes]","volume":"40","author":"Steiger","year":"2019","journal-title":"Pathologe"},{"issue":"8","key":"10.1016\/j.labinv.2025.104242_bib29","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1007\/s10620-021-07303-9","article-title":"FGFR2-IIIb expression by immunohistochemistry has high specificity in cholangiocarcinoma with FGFR2 genomic alterations","volume":"67","author":"Uson Junior","year":"2022","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.labinv.2025.104242_bib30","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1002\/hep.32344","article-title":"Cholangiocarcinoma progression depends on the uptake and metabolization of extracellular lipids","volume":"76","author":"Ruiz de Gauna","year":"2022","journal-title":"Hepatology"},{"issue":"43","key":"10.1016\/j.labinv.2025.104242_bib31","doi-asserted-by":"crossref","first-page":"12250","DOI":"10.1073\/pnas.1600067113","article-title":"Notch3 drives development and progression of cholangiocarcinoma","volume":"113","author":"Guest","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.labinv.2025.104242_bib32","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1158\/0008-5472.CAN-11-3596","article-title":"Kras(G12D) and p53 mutation cause primary intrahepatic cholangiocarcinoma","volume":"72","author":"O'Dell","year":"2012","journal-title":"Cancer Res"},{"issue":"3","key":"10.1016\/j.labinv.2025.104242_bib33","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/liv.15152","article-title":"Preneoplastic lesions in the liver: molecular insights and relevance for clinical practice","volume":"42","author":"Desjonqueres","year":"2022","journal-title":"Liver Int"},{"issue":"1","key":"10.1016\/j.labinv.2025.104242_bib34","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1186\/s13046-022-02536-6","article-title":"Crenigacestat blocking notch pathway reduces liver fibrosis in the surrounding ecosystem of intrahepatic CCA viaTGF-\u03b2 inhibition","volume":"41","author":"Mancarella","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.labinv.2025.104242_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1053\/j.gastro.2022.05.007","article-title":"NOTCH-YAP1\/TEAD-DNMT1 axis drives hepatocyte reprogramming into intrahepatic cholangiocarcinoma","volume":"163","author":"Hu","year":"2022","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.labinv.2025.104242_bib36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/14728222.2017.1310842","article-title":"Role of the Notch signaling in cholangiocarcinoma","volume":"21","author":"Cigliano","year":"2017","journal-title":"Expert Opin Ther Targets"},{"issue":"8","key":"10.1016\/j.labinv.2025.104242_bib37","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1007\/s13277-015-3261-1","article-title":"Differentially expressed gene profiles of intrahepatic cholangiocarcinoma, hepatocellular carcinoma, and combined hepatocellular-cholangiocarcinoma by integrated microarray analysis","volume":"36","author":"Xue","year":"2015","journal-title":"Tumour Biol"},{"issue":"6","key":"10.1016\/j.labinv.2025.104242_bib38","first-page":"3272","article-title":"Clinicopathological significance of aberrant Notch receptors in intrahepatic cholangiocarcinoma","volume":"7","author":"Wu","year":"2014","journal-title":"Int J Clin Exp Pathol"},{"issue":"10","key":"10.1016\/j.labinv.2025.104242_bib39","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1158\/2159-8290.CD-17-0368","article-title":"Whole-genome and epigenomic landscapes of etiologically distinct subtypes of cholangiocarcinoma","volume":"7","author":"Jusakul","year":"2017","journal-title":"Cancer Discov"},{"issue":"24","key":"10.1016\/j.labinv.2025.104242_bib40","doi-asserted-by":"crossref","first-page":"3838","DOI":"10.1002\/cncr.30254","article-title":"Biliary cancer: utility of next-generation sequencing for clinical management","volume":"122","author":"Javle","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.labinv.2025.104242_bib41","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1038\/ncomms6696","article-title":"Mutational landscape of intrahepatic cholangiocarcinoma","volume":"5","author":"Zou","year":"2014","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.labinv.2025.104242_bib42","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1038\/ng.2806","article-title":"Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers","volume":"45","author":"Chan-On","year":"2013","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.labinv.2025.104242_bib43","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/ng.2273","article-title":"Exome sequencing of liver fluke-associated cholangiocarcinoma","volume":"44","author":"Ong","year":"2012","journal-title":"Nat Genet"},{"issue":"6","key":"10.1016\/j.labinv.2025.104242_bib44","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.jhep.2022.07.022","article-title":"Current epidemiology of cholangiocarcinoma in Western countries","volume":"77","author":"Vithayathil","year":"2022","journal-title":"J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.labinv.2025.104242_bib45","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/liv.14095","article-title":"Cholangiocarcinoma: epidemiology and risk factors","volume":"39","author":"Khan","year":"2019","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.labinv.2025.104242_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2016.73","article-title":"Jagged 1 is a major Notch ligand along cholangiocarcinoma development in mice and humans","volume":"5","author":"Che","year":"2016","journal-title":"Oncogenesis"},{"issue":"5","key":"10.1016\/j.labinv.2025.104242_bib47","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/s41419-020-2509-x","article-title":"Oncogenic driver genes and tumor microenvironment determine the type of liver cancer","volume":"11","author":"Wang","year":"2020","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.labinv.2025.104242_bib48","doi-asserted-by":"crossref","first-page":"22","DOI":"10.21037\/hbsn.2016.11.04","article-title":"Pathology of intrahepatic cholangiocarcinoma","volume":"6","author":"Vijgen","year":"2017","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"6","key":"10.1016\/j.labinv.2025.104242_bib49","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s00268-009-9970-0","article-title":"Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection","volume":"33","author":"Guglielmi","year":"2009","journal-title":"World J Surg"},{"issue":"5","key":"10.1016\/j.labinv.2025.104242_bib50","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.surg.2019.12.009","article-title":"Effect of surgical margin width after R0 resection for intrahepatic cholangiocarcinoma: a nationwide survey of the Liver Cancer Study Group of Japan","volume":"167","author":"Watanabe","year":"2020","journal-title":"Surgery"},{"issue":"7","key":"10.1016\/j.labinv.2025.104242_bib51","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/modpathol.2017.22","article-title":"Dichotomy in intrahepatic cholangiocarcinomas based on histologic similarities to hilar cholangiocarcinomas","volume":"30","author":"Akita","year":"2017","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.labinv.2025.104242_bib52","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/PAS.0000000000000670","article-title":"Distinct clinicopathologic and genetic features of 2 histologic subtypes of intrahepatic cholangiocarcinoma","volume":"40","author":"Hayashi","year":"2016","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"10.1016\/j.labinv.2025.104242_bib53","doi-asserted-by":"crossref","first-page":"13","DOI":"10.5009\/gnl15568","article-title":"Cholangiocarcinoma: current knowledge and new developments","volume":"11","author":"Blechacz","year":"2017","journal-title":"Gut Liver"},{"issue":"8","key":"10.1016\/j.labinv.2025.104242_bib54","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/modpathol.2013.241","article-title":"Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features","volume":"27","author":"Liau","year":"2014","journal-title":"Mod Pathol"},{"issue":"13","key":"10.1016\/j.labinv.2025.104242_bib55","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.3390\/cancers14133156","article-title":"Integrative analysis of intrahepatic cholangiocarcinoma subtypes for improved patient stratification: clinical, pathological, and radiological considerations","volume":"14","author":"Gerber","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.labinv.2025.104242_bib56","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/PAS.0000000000001118","article-title":"Intrahepatic cholangiocarcinomas have histologically and immunophenotypically distinct small and large duct patterns","volume":"42","author":"Sigel","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"9","key":"10.1016\/j.labinv.2025.104242_bib57","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nrgastro.2011.131","article-title":"Clinical diagnosis and staging of cholangiocarcinoma","volume":"8","author":"Blechacz","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"3","key":"10.1016\/j.labinv.2025.104242_bib58","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/hep.20837","article-title":"Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions","volume":"42","author":"Yeh","year":"2005","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.labinv.2025.104242_bib59","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/labinvest.3700087","article-title":"Aberrant expression of CDX2 is closely related to the intestinal metaplasia and MUC2 expression in intraductal papillary neoplasm of the liver in hepatolithiasis","volume":"84","author":"Ishikawa","year":"2004","journal-title":"Lab Invest"},{"key":"10.1016\/j.labinv.2025.104242_bib60","article-title":"Up-to-date pathologic classification and molecular characteristics of intrahepatic cholangiocarcinoma","volume":"9","author":"Chung","year":"2022","journal-title":"Front Med (Lausanne)"},{"issue":"6","key":"10.1016\/j.labinv.2025.104242_bib61","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3390\/ijms20061288","article-title":"Mucins: the old, the new and the promising factors in hepatobiliary carcinogenesis","volume":"20","author":"Kasprzak","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.labinv.2025.104242_bib62","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.humpath.2018.04.010","article-title":"Mucinous intrahepatic cholangiocarcinoma: a distinct variant","volume":"78","author":"Chi","year":"2018","journal-title":"Hum Pathol"},{"issue":"8","key":"10.1016\/j.labinv.2025.104242_bib63","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.3390\/cancers16081537","article-title":"Recent advances in pathology of intrahepatic cholangiocarcinoma","volume":"16","author":"Choi","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"6","key":"10.1016\/j.labinv.2025.104242_bib64","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1111\/his.15162","article-title":"Heterogeneity of small duct- and large duct-type intrahepatic cholangiocarcinoma","volume":"84","author":"Kinzler","year":"2024","journal-title":"Histopathology"},{"key":"10.1016\/j.labinv.2025.104242_bib65","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.humpath.2022.06.001","article-title":"Intrahepatic cholangiocarcinoma: typical features, uncommon variants, and controversial related entities","volume":"132","author":"Zen","year":"2023","journal-title":"Hum Pathol"},{"issue":"9","key":"10.1016\/j.labinv.2025.104242_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0106675","article-title":"Design and development of a robotized system coupled to \u03bcCT imaging for intratumoral drug evaluation in a HCC mouse model","volume":"9","author":"Bour","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.labinv.2025.104242_bib67","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/mc.2940060210","article-title":"p53 mutations are absent from carcinogen-induced mouse liver tumors but occur in cell lines established from these tumors","volume":"6","author":"Kress","year":"1992","journal-title":"Mol Carcinog"},{"issue":"1","key":"10.1016\/j.labinv.2025.104242_bib68","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-92128-9","article-title":"Establishment of liver tumor cell lines from atherogenic and high fat diet fed hepatitis C virus transgenic mice","volume":"11","author":"Shirasaki","year":"2021","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.labinv.2025.104242_bib69","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1038\/s41598-018-21121-6","article-title":"Induction of differentiation of intrahepatic cholangiocarcinoma cells to functional hepatocytes using an organoid culture system","volume":"8","author":"Saito","year":"2018","journal-title":"Sci Rep"},{"issue":"11","key":"10.1016\/j.labinv.2025.104242_bib70","doi-asserted-by":"crossref","first-page":"3914","DOI":"10.1172\/JCI63065","article-title":"Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes","volume":"122","author":"Sekiya","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/j.labinv.2025.104242_bib71","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/bs.acr.2020.10.005","article-title":"Intrahepatic cholangiocarcinoma: morpho-molecular pathology, tumor reactive microenvironment, and malignant progression","volume":"149","author":"Sirica","year":"2021","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.labinv.2025.104242_bib72","doi-asserted-by":"crossref","first-page":"293","DOI":"10.3389\/fmed.2019.00293","article-title":"Inflammation and progression of cholangiocarcinoma: role of angiogenic and lymphangiogenic mechanisms","volume":"6","author":"Roy","year":"2019","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.labinv.2025.104242_bib73","article-title":"M2 macrophage inhibits the antitumor effects of lenvatinib on intrahepatic cholangiocarcinoma","volume":"14","author":"Yang","year":"2023","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.labinv.2025.104242_bib74","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13045-022-01253-z","article-title":"Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses","volume":"15","author":"Xia","year":"2022","journal-title":"J Hematol Oncol"},{"issue":"4","key":"10.1016\/j.labinv.2025.104242_bib75","first-page":"597","article-title":"Tissue invasive macrophage density is correlated with prognosis in cholangiocarcinoma","volume":"3","author":"Subimerb","year":"2010","journal-title":"Mol Med Rep"},{"issue":"1","key":"10.1016\/j.labinv.2025.104242_bib76","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1038\/s41598-024-52991-8","article-title":"Activated FGFR2 signalling as a biomarker for selection of intrahepatic cholangiocarcinoma patients candidate to FGFR targeted therapies","volume":"14","author":"Brandi","year":"2024","journal-title":"Sci Rep"},{"issue":"12","key":"10.1016\/j.labinv.2025.104242_bib77","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/ijc.34350","article-title":"Cholangiocarcinoma cell proliferation is enhanced in primary sclerosing cholangitis: a role for IL-17A","volume":"152","author":"Lieshout","year":"2023","journal-title":"Int J Cancer"},{"issue":"7","key":"10.1016\/j.labinv.2025.104242_bib78","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3390\/app9071393","article-title":"Role of the angiogenic factors in cholangiocarcinoma","volume":"9","author":"Mancinelli","year":"2019","journal-title":"Appl Sci"},{"issue":"3","key":"10.1016\/j.labinv.2025.104242_bib79","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jhep.2017.03.026","article-title":"Emerging molecular therapeutic targets for cholangiocarcinoma","volume":"67","author":"Ilyas","year":"2017","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.labinv.2025.104242_bib80","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.bcp.2013.06.020","article-title":"Animal models of disease: pre-clinical animal models of cancer and their applications and utility in drug discovery","volume":"87","author":"Ruggeri","year":"2014","journal-title":"Biochem Pharmacol"}],"container-title":["Laboratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683725001527?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0023683725001527?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T07:06:25Z","timestamp":1780729585000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0023683725001527"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":80,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0023683725001527"],"URL":"https:\/\/doi.org\/10.1016\/j.labinv.2025.104242","relation":{},"ISSN":["0023-6837"],"issn-type":[{"value":"0023-6837","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Detailed Characterization and Comparison of Mouse Models for Cholangiocarcinoma","name":"articletitle","label":"Article Title"},{"value":"Laboratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.labinv.2025.104242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 THE AUTHORS. Published by Elsevier Inc. on behalf of the United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}],"article-number":"104242"}}